Clinical Trials Logo

Clinical Trial Summary

The major risk factors of aortic valve replacement in three outlet types VSD after surgical repair were the severity of preoperative AR and older operation age. For those patients with less than moderate degree AR preoperatively, AR progressed rarely and all in those with aortic valvar and subvalvar anomalies.


Clinical Trial Description

Progression of aortic regurgitation (AR) in repaired outlet (juxta-arterial, muscular outlet and perimembranous outlet) ventricular septal defect (VSD) remains unclear.

From 1987 to 2002, 411 patients with complete follow-up after repair of outlet VSD constituted the study population. Study end point was aortic valve replacement or mortality.

Aortic valve replacement was performed in seventeen patients (4.1%), in whom logistic regression showed only the severity of preoperative AR and age at VSD repair as the predictors. After excluding the eleven patients with endocarditis from analysis, there were 377 patients with none to mild AR (Group I) and 23 with moderate to severe AR (Group II) preoperatively. Total follow-up was 2,230 person-years. After VSD repair, the 5- and 10-year freedom from aortic valve replacement in Group I was 100%, and in Group II 50.2%. In Group II, ten patients received aortic valve replacement and 8 underwent valvuloplasty with VSD repair. One patient needed valve replacement four years later. Age at VSD repair was the predictor for aortic valve replacement. In Group I, AR progressed in four patients (1.2%, two juxta-arterial and two perimembranous outlet) 3.5 to 7.9 years later and was associated with aortic valvar or subvalvar anomalies. The event-free curves in three outlet types VSD showed no differences.

Although AR progressed rarely (probably not in muscular outlet type) in repaired outlet types VSD with none to mild preoperative AR, in the presence of aortic valvar or subvalvar anomalies, early surgical repair of the VSD is still warranted. ;


Study Design

Observational Model: Case Control, Time Perspective: Longitudinal


Related Conditions & MeSH terms


NCT number NCT00173186
Study type Observational
Source National Taiwan University Hospital
Contact Mei-Hwan Wu, MD, PhD
Phone 886-2-23123456
Email mhwu@ha.mc.ntu.edu.tw
Status Recruiting
Phase N/A
Start date January 1987
Completion date February 2005

See also
  Status Clinical Trial Phase
Recruiting NCT04149600 - Identification of Genetic Causes of Calcific Aortic Valve Disease
Enrolling by invitation NCT04035356 - HAART Annuloplasty Device Valve Repair Registry
Unknown status NCT01201070 - Study of Administration Of Antithrombin in Patients With Low Plasmatic Levels of Antithrombin After Cardiac Surgery Phase 4
Active, not recruiting NCT04281771 - Assessment of Paravalvular Leak After TAVI by Hemodynamic Measurements and Cardiac MRI N/A
Completed NCT03644784 - Protocoled Quantitative Assessment of Aortic Regurgitation Using Videodensitometry in a Multicontinental Trial in Rotterdam, Montreal, Yamaguchi, Segeberg, Amsterdam.
Recruiting NCT02288871 - Pilot Trial: Comparison of Flow Patterns N/A
Completed NCT01651780 - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH Phase 3
Completed NCT01171625 - Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX N/A
Terminated NCT00598598 - Echocardiographic Assessment of Cardiovascular Changes in Long Term Space Flight N/A
Recruiting NCT05295628 - Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR N/A
Recruiting NCT06034028 - J-Valve TF Early Feasibility Study N/A
Recruiting NCT06295068 - Evaluation of ARi With OpSens SavvyWire
Completed NCT05742789 - Effect of Anesthetics on Troponin I and С-reactive Protein Phase 1
Recruiting NCT05172973 - ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves N/A
Completed NCT00727181 - An Observational, Prospective Evaluation of the Trifecta™ Valve N/A
Active, not recruiting NCT04415047 - The JenaValve ALIGN-AR Pivotal Trial N/A
Not yet recruiting NCT02623907 - China Valve Registry Study-1 N/A
Completed NCT00478803 - Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR Phase 3
Completed NCT00475267 - Aortic Valve Replacement With Trifecta(TM) N/A
Completed NCT00001314 - Investigation of Heart Function in Patients With Heart Valve Defects N/A